sunitinib mylan kõvakapsel
mylan ireland limited - sunitiniib - kõvakapsel - 12,5mg 30tk
sunitinib mylan kõvakapsel
mylan ireland limited - sunitiniib - kõvakapsel - 50mg 28tk
sunitinib zentiva kõvakapsel
zentiva k.s. - sunitiniib - kõvakapsel - 12,5mg 28tk
sunitinib zentiva kõvakapsel
zentiva k.s. - sunitiniib - kõvakapsel - 50mg 28tk; 50mg 30tk
sunitinib accord
accord healthcare s.l.u. - sunitiniib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - antineoplastilised ained - gastrointestinal stromal tumour (gist)sunitinib accord is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sunitinib accord is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sunitinib accord is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours (pnet) with disease progression in adults.
lextemy
mylan ire healthcare limited - bevatsizumab - colorectal neoplasms; breast neoplasms; ovarian neoplasms; fallopian tube neoplasms; peritoneal neoplasms; carcinoma, non-small-cell lung; carcinoma, renal cell; uterine cervical neoplasms - antineoplastilised ained - treatment of carcinoma of the colon or rectum, breast cancer, non-small cell lung cancer, renal cell cancer, epithelial ovarian, fallopian tube or primary peritoneal cancer, and carcinoma of the cervix.
sunitinib stada kõvakapsel
stada arzneimittel ag - sunitiniib - kõvakapsel - 37,5mg 30tk; 37,5mg 28tk
sunitinib stada kõvakapsel
stada arzneimittel ag - sunitiniib - kõvakapsel - 50mg 30tk; 50mg 28tk
sunitinib stada kõvakapsel
stada arzneimittel ag - sunitiniib - kõvakapsel - 12,5mg 30tk
sunitinib stada kõvakapsel
stada arzneimittel ag - sunitiniib - kõvakapsel - 25mg 28tk; 25mg 30tk